Welcome to our dedicated page for HORTON D R /DE/ SEC filings (Ticker: DHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HORTON D R /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HORTON D R /DE/'s regulatory disclosures and financial reporting.
A Form 144 filing by D.R. Horton indicates a proposed sale of 2,150 shares of common stock with an aggregate market value of $274,552. The sale is planned to be executed through Charles Schwab & Co. on the NYSE, with an approximate sale date of June 24, 2025.
The shares to be sold were acquired through multiple restricted stock lapses:
- 254 shares on 11/26/2022
- 470 shares on 11/26/2023
- 763 shares on 01/26/2024
- 663 shares on 01/26/2025
All shares were received as equity compensation from the company. The total outstanding shares of D.R. Horton common stock are 307,181,294. No other securities were reported as sold by the filer during the past 3 months.
Form 4 alert: D.R. Horton, Inc. (DHI) director Michael R. Buchanan disclosed the sale of 2,150 common shares on 24 Jun 2025 at a weighted-average price of $127.6988, generating proceeds of roughly $274k. The transaction was coded “S,” indicating an open-market sale rather than option exercise or other derivative activity. After the trade, Buchanan’s direct ownership falls to 2,193 shares, while he continues to hold 8,136 shares indirectly through his spouse, for a combined beneficial position of 10,329 shares.
The filing notes that the price range for the sale was $127.53–$127.895; detailed breakdowns are available on request. No derivative transactions were reported, and the filing does not reference a Rule 10b5-1 trading plan.
Relative impact: the disposed shares represent roughly 49% of Buchanan’s direct stake but are immaterial versus DHI’s ~357 million shares outstanding. Insider sales can signal limited near-term enthusiasm, yet a single, modest-sized sale—worth <0.01% of daily trading volume—typically carries limited market significance. Investors may monitor future filings for any pattern of continued selling.